Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions under "Our services"

Valuation: Orion Oyj

Market Cap 9.65B 11.04B 8.93B 8.33B 15.64B 1,044B 15.75B 106B 41.27B 513B 41.46B 40.56B 1,782B P/E 2026 *
17.5x
P/E 2027 * 14.9x
Enterprise Value 9.55B 10.93B 8.83B 8.24B 15.48B 1,033B 15.59B 105B 40.84B 508B 41.03B 40.14B 1,764B EV / Sales 2026 *
4.59x
EV / Sales 2027 * 3.97x
Free-Float
90.5%
Yield 2026 *
2.78%
Yield 2027 * 3.09%
1 day+2.39%
1 week+2.70%
Current month-3.66%
1 month-3.79%
3 months-0.72%
6 months+9.42%
Current year+8.21%
1 week 66
Extreme 66
68.5
1 month 66
Extreme 66
72
Current year 62.3
Extreme 62.3
75.1
1 year 56.3
Extreme 56.3
75.1
3 years 32.5
Extreme 32.5
75.1
5 years 32.5
Extreme 32.5
75.1
10 years 24.75
Extreme 24.75
75.1
Manager TitleAgeSince
Chief Executive Officer 59 2022-10-31
Director of Finance/CFO 50 2024-04-30
Chief Operating Officer 46 2021-12-31
Director TitleAgeSince
Director/Board Member 63 2017-03-21
Director/Board Member 65 2017-03-21
Director/Board Member 66 2020-05-05
Change 5-day change 1-year change 3-year change Capi.($)
+2.39%+2.70% - - 10.87B
+0.32%-2.41%+44.49%+140.80% 980B
+1.27%-1.85%+54.41%+39.65% 550B
+6.25%+3.80%+24.13%+67.39% 382B
+0.25%-1.93%+23.33%+16.35% 316B
+0.42%+0.68%+27.89%+14.57% 272B
+1.67%+0.05%+26.76%+33.56% 268B
+2.39%+5.02%-36.96%-44.76% 199B
+2.11%-1.66%+19.14%+50.10% 182B
+0.90%+0.46%+15.09%+59.86% 154B
Average +1.80%-1.61%+22.03%+41.95% 366.93B
Weighted average by Cap. +1.53%-2.66%+31.28%+64.51%

Financials

2026 *2027 *
Net sales 2.08B 2.38B 1.92B 1.8B 3.37B 225B 3.4B 22.87B 8.9B 111B 8.94B 8.75B 384B 2.35B 2.69B 2.18B 2.03B 3.81B 254B 3.84B 25.85B 10.06B 125B 10.1B 9.88B 434B
Net income 550M 629M 508M 474M 891M 59.43B 897M 6.04B 2.35B 29.22B 2.36B 2.31B 102B 649M 743M 600M 560M 1.05B 70.21B 1.06B 7.14B 2.78B 34.52B 2.79B 2.73B 120B
Net Debt -101M -115M -93.1M -86.9M -163M -10.89B -164M -1.11B -430M -5.35B -432M -423M -18.59B -313M -358M -289M -270M -507M -33.82B -511M -3.44B -1.34B -16.63B -1.34B -1.31B -57.77B
Logo Orion Oyj
Orion Oyj is Finland's leading pharmaceutical group. Net sales break down by family products and services as follows: - innovative medicines (43%): for the treatment of cancer and pain management; - generic, OTC and biosimilar drugs (29.3%); - branded prescription products (16.6%): notably intended for treating dysfunctions of the nervous system, cardiovascular diseases, hormonal and urological treatments; - veterinary products (7.5%); - pharmaceutical ingredients and outsourcing services (3.6%). Net sales break down primarily by source of revenue between sales of products (67.2%) and royalties (23.1%). Net sales are distributed geographically as follows: Finland (19.3%), Scandinavia (10%), Europe (28.1%), North America (25.5%) and other (17.1%).
Employees
4,132
Date Price Change Volume
26-06-22 68.50 +2.39% 2,003
26-06-18 66.90 -2.05% 8,918
26-06-17 68.30 +1.64% 2,119
26-06-16 67.20 +0.75% 19,036
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
68.50EUR
Average target price
74.33EUR
Spread / Average Target
+8.52%

Quarterly revenue - Rate of surprise

-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!